• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Merz

Dr. Gawande tapped to lead Amazon-JPM-Berkshire health play | Personnel Moves – June 21, 2018

June 21, 2018 By Fink Densford

The joint healthcare venture between Amazon (NSDQ:AMZN), Berkshire Hathaway and J.P. Morgan Chase said this week it named Brigham and Women’s Hospital surgeon, New Yorker magazine staff writer and bestselling author Dr. Atul Gawande as its CEO, effective July 9. The joint venture said that the newly formed company will be headquartered in Boston, and will operate […]

Filed Under: Business/Financial News Tagged With: AirXpanders, Amazon, Avantis Medical Systems Inc., Berkshire Hathaway, Boston Scientific, CHF Solutions Inc., Corindus Vascular Robotics, Haemonetics, Intuitive Surgical, IsoRay, JP Morgan Chase, medicen, Medtronic, Merz, MRI Interventions, Pivot Medical, Stimwave

Silicone patch for laser-assisted tattoo removal wins new FDA clearance

December 4, 2017 By Sarah Faulkner

Merz North America said today that its Describe PFD patch was cleared by the FDA for all commonly-used lasers. The single-use, perfluorodecalin-infused patch is used during laser-assisted tattoo removal to allow for multiple passes in a single treatment session. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: Merz

Acelity taps Eckert to succeed Woody as CEO| Personnel Moves | April 5, 2017

April 5, 2017 By Brad Perriello

Acelity said today it tapped R. Eckert as its new prez & CEO, succeeding Joseph Woody who is stepping away from Acelity following the company’s divestiture of its LifeCell division earlier this year. Eckert previously served as CEO of health information tech company TriZetto Corp, and has led 5 other companies including CRC Health Group, Eclipsys […]

Filed Under: Business/Financial News Tagged With: AdvaMed, advastim, Dynatronics Corp, InfoBionic, Iradimed Corp, LivaNova, Merz, Personnel Moves, STAAR Surgical Co, titanmedical

Merz buys tattoo-removal company ON Light Sciences

August 17, 2016 By Fink Densford

Healthcare company Merz said today it picked up On Light Sciences, makers of the DeScribe Transparent perfluorodecalin patch designed for laser tattoo removal, for an undisclosed amount. Raleigh, N.C.-based Merz said the DeScribe device has FDA 510(k) clearance and CE Mark approval in the European Union for the device, and that the patch will be folded […]

Filed Under: Business/Financial News, Cosmetic/Aesthetic, Mergers & Acquisitions Tagged With: Merz, On Light Sciences

Medtronic shareholder sues to block pending merger with Covidien | The week in medtech M&A

July 30, 2014 By MassDevice Leave a Comment

Report: Medtronic shareholder sues to block Covidien merger

July 24, 2014 by Brad Perriello

Filed Under: Mergers & Acquisitions, News Well Tagged With: Covidien, Elekta, Merz, Mesi Medikal, Ulthera Inc., Visualase

Ulthera pulls $86M IPO in favor of $600M merger

July 23, 2014 By Arezu Sarvestani Leave a Comment

Ulthera pulls IPO in favor of merger

Arizona device maker Ulthera is ditching its planned initial public offering in favor of a $600 million merger with larger aesthetics company Merz Inc., according to an SEC filing.

Filed Under: Cosmetic/Aesthetic, Initial Public Offering (IPO), Mergers & Acquisitions, News Well, Ultrasound Tagged With: Merz, Ulthera Inc.

Diabetes: Medtronic wins clearance for next-gen clinical continuous glucose monitor | Regulatory Roundup

November 25, 2011 By MassDevice staff Leave a Comment

Medtronic logo

Medtronic Inc. (NYSE:MDT) won FDA clearance for its next generation iPro2 Professional continuous glucose monitor.

The iPro2 Professional is a clinician-owned device that collects glucose data from a sensor inserted into a patient’s skin.

The device tracks the patient’s glucose levels for 3 days, collecting data as many as 288 times each day. The information may provide insight into how diet, medication and daily activities affect a patient’s glucose levels.

Filed Under: News Well Tagged With: BSD Medical Corp., Canon, CerMed International, Clinical Trials, Dendreon Corp., Fujifilm, IntriCon Corp., IsoRay, Merz, neovasc, Regulatory Roundup, Retina Implant AG, STAAR Surgical Co, Translational Sciences Corp., Vascular Designs Inc.

Primary Sidebar

DeviceTalks Weekly

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS